MYNZ
Mainz Biomed B.V.
NASDAQ · Healthcare · Medical - Diagnostics & Research · DE
$3.59
+0.84%Leverage
- Debt / equity
- 1.23x
- Net debt / equity
- 0.47x
- Debt / assets
- 0.32x
- Debt / EBITDA
- -0.08x
- Net debt / EBITDA
- -0.03x
Liquidity & coverage
- Current ratio
- 0.52x
- Quick ratio
- 0.43x
- Cash ratio
- 0.32x
- Interest coverage
- -14.93x
- EBITDA / interest
- -15.28x
- Working capital
- -$2.9M
Cash & dividend
- FCF / debt
- -9.30x
- Cash flow / debt
- -9.14x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Dec 1, 2025